For example, ATG7 deficiency strongly attenuates the growth of intestinal tumors, accompanied by metabolic defects, AMPK (5′ AMP-activated protein kinase) activation, and p53-mediated cell cycle arrest in a relevant preclinical animal tumor model.32 Here, TP53 is linked to intestinal neoplasm.